Vivo Bio Tech Valuation

Is 511509 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 511509 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 511509's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 511509's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 511509?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 511509. This is calculated by dividing 511509's market cap by their current preferred multiple.
What is 511509's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	₹571.70m

511509 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.9x
Enterprise Value/EBITDA	6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 511509's PE Ratio compare to its peers?

The above table shows the PE ratio for 511509 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	48.5x
524394 Vimta Labs	30.9x	n/a	₹12.7b
544184 Borosil Scientific	66.2x	n/a	₹16.7b
TARSONS Tarsons Products	58.5x	27.5%	₹21.7b
WINDLAS Windlas Biotech	38.5x	n/a	₹22.9b
511509 Vivo Bio Tech	22.4x	n/a	₹571.7m

Price-To-Earnings vs Peers: 511509 is good value based on its Price-To-Earnings Ratio (22.4x) compared to the peer average (48.5x).

Price to Earnings Ratio vs Industry

How does 511509's PE Ratio compare vs other companies in the Asian Life Sciences Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	21.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	21.4%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 511509 is good value based on its Price-To-Earnings Ratio (22.4x) compared to the Asian Life Sciences industry average (29.2x).

Price to Earnings Ratio vs Fair Ratio

What is 511509's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

511509 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	22.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 511509's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.